GlobalData on MSN
Neurovalens receives EU MDR compliance for sleep insomnia device
Achieving MDR compliance shows Modius Sleep meets safety, clinical, and quality standards required for entry into the EU ...
Neurovalens announced today that it received approval for its first neuromodulation product in Europe and the UK.
Modius Sleep is currently available via prescription in the US for $2,265 (£1,690) ...
95 percent of clinical trial participants reported better sleep in four weeks BELFAST, Northern Ireland, Oct. 28, 2024 /PRNewswire/ -- Neurovalens, a global health-tech leader in neurotechnology, has ...
BELFAST, Northern Ireland, Feb. 24, 2025 /PRNewswire/ -- Neurovalens, a global leader in noninvasive neurostimulation technology, is making significant strides in addressing chronic insomnia among U.S ...
SAN DIEGO, Nov. 12, 2019 /PRNewswire/ -- Neurovalens, a global HealthTech company focused on developing innovative neuroscience-powered products to improve lives, today launches its Modius SLEEP ...
Belfast News Letter on MSN
'Another significant landmark': Northern Ireland medical tech manufacturer granted EU and UK approval for innovative insomnia device
Modius Sleep, a non-invasive, prescription-only neurostimulation device, offers a new drug-free approach to treating insomnia ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results